MarketsStocksAUROPHARMA
AU

Aurobindo Pharma

NSE: AUROPHARMABSE: 524804Healthcare
Download Research Report7-page PDF
1,446.00
-1.11%
NSE · auto-updates while market open
Prev Close
₹1,161.10
Day High
₹1,478.50
Day Low
₹1,445.90
Mkt Cap
₹84,083 Cr
P / E
24.0
P / B
2.2
ROE
9.9%
52W High
₹1,550.00
52W Low
₹1,016.10
Key Metrics
Market Cap
₹84,083 Cr
P / E
24.01
P / B
2.22
EV / EBITDA
12.20
ROCE
12.8%
ROE
9.9%
Debt / Equity
0.20
Book Value
₹652.39
EPS
₹60.34
Div Yield
0.3%
Face Value
₹1
Promoter Holding
51.8%
Revenue · ₹ Cr
23k
FY20
25k
FY21
23k
FY22
25k
FY23
29k
FY24
32k
FY25
34k
FY26
Net Profit · ₹ Cr
2.8k
FY20
5.3k
FY21
2.6k
FY22
1.9k
FY23
3.2k
FY24
3.5k
FY25
3.5k
FY26
EPS · ₹ per share
₹48.3
FY20
₹91.0
FY21
₹45.2
FY22
₹32.9
FY23
₹54.2
FY24
₹59.8
FY25
₹60.3
FY26
P / E Ratio · price ÷ TTM EPS
5132130104480-7Jun 21Feb 23Oct 24Jun 26
P/E 24.1×Median 19.3×TTM EPS
Q1 2026 snapshot
Sales
₹8.97K Cr
Operating profit
-
OPM
-
Net profit
₹921 Cr
EPS
₹15.86
Scorecard · 7 axes
Quality
Avg
49/100
Valuation
Good
24.0×
Growth
Avg
+8.3%
Profitability
Avg
11.3%
Performance
Good
+26.1%
Entry Point
Weak
93%
Red Flags
Strong
0 flags
Shareholding Pattern
51.8%Promoter
Promoter51.8%
FII15.2%
DII25.9%
Public7.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue7,978.528,516.937,973.448,406.298,833.548,970.38
Net Profit845.57902.83824.2848.13909.8920.84
NPM %10.6%10.6%10.3%10.1%10.3%10.3%
AlertPre-trade